Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 3
1992 6
1993 6
1994 4
1995 7
1996 5
1997 7
1998 14
1999 8
2000 5
2001 9
2002 8
2003 6
2004 7
2005 8
2006 9
2007 9
2008 9
2009 4
2010 2
2011 1
2012 3
2013 4
2014 6
2015 3
2016 6
2017 4
2018 4
2019 3
2020 6
2021 9
2022 11
2023 7
2024 10
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C, Pagliuca S, Prata PH, Galimard JE, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Sicre de Fontbrune F, Voso MT, Visconte V, Peffault de Latour R, Soulier J, Calado RT, Socié G, Maciejewski JP. Gurnari C, et al. Among authors: caillat zucman s. J Clin Oncol. 2023 Jan 1;41(1):132-142. doi: 10.1200/JCO.22.00710. Epub 2022 Sep 2. J Clin Oncol. 2023. PMID: 36054881 Free PMC article.
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Boulch M, Cazaux M, Cuffel A, Guerin MV, Garcia Z, Alonso R, Lemaître F, Beer A, Corre B, Menger L, Grandjean CL, Morin F, Thieblemont C, Caillat-Zucman S, Bousso P. Boulch M, et al. Among authors: caillat zucman s. Nat Cancer. 2023 Jul;4(7):968-983. doi: 10.1038/s43018-023-00570-7. Epub 2023 May 29. Nat Cancer. 2023. PMID: 37248395 Free PMC article.
Cytolytic circumsporozoite-specific memory CD4+ T cell clones are expanded during Plasmodium falciparum infection.
Furtado R, Paul M, Zhang J, Sung J, Karell P, Kim RS, Caillat-Zucman S, Liang L, Felgner P, Bauleni A, Gama S, Buchwald A, Taylor T, Seydel K, Laufer M, Delahaye F, Daily JP, Lauvau G. Furtado R, et al. Among authors: caillat zucman s. Nat Commun. 2023 Nov 25;14(1):7726. doi: 10.1038/s41467-023-43376-y. Nat Commun. 2023. PMID: 38001069 Free PMC article.
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study.
Delyon J, Biard L, Renaud M, Resche-Rigon M, Le Goff J, Dalle S, Heidelberger V, Da Meda L, Toullec L, Carcelain G, Mourah S, Caillat-Zucman S, Allain V, Battistella M, Lebbe C. Delyon J, et al. Among authors: caillat zucman s. Lancet Oncol. 2022 Apr;23(4):491-500. doi: 10.1016/S1470-2045(22)00097-3. Epub 2022 Mar 10. Lancet Oncol. 2022. PMID: 35279271 Clinical Trial.
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S. Herbaux C, et al. Among authors: caillat zucman s. Haematologica. 2024 Nov 1;109(11):3745-3750. doi: 10.3324/haematol.2023.284786. Haematologica. 2024. PMID: 38899352 Free PMC article. No abstract available.
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.
Chevalier MF, Allain V, Gras J, Racle J, Villemonteix J, Divard G, Feghoul L, Delaugerre C, Molina JM, Taupin JL, Peraldi MN, Gfeller D, Feray C, Caillat-Zucman S. Chevalier MF, et al. Among authors: caillat zucman s. Sci Adv. 2025 Mar 7;11(10):eadt3499. doi: 10.1126/sciadv.adt3499. Epub 2025 Mar 5. Sci Adv. 2025. PMID: 40043107 Free PMC article.
[CAR-T cell development and other gene therapy: Everything is not so easy].
Dalle JH, Baudoux E, Caillat-Zucman S, Colledani F, Pereira M, Bruno B, Nguyen S, Robin M, Rubio MT, Bay JO. Dalle JH, et al. Among authors: caillat zucman s. Bull Cancer. 2020 Apr;107(4):408-409. doi: 10.1016/j.bulcan.2020.03.002. Bull Cancer. 2020. PMID: 32334675 French. No abstract available.
A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI/PRIMO.
Essat A, Chapel A, Amokrane K, Monceaux V, Didier C, Melard A, Gardiennet E, Avettand-Fenoel V, Orr S, Boufassa F, Lambotte O, Müller-Trutwin M, Lécuroux C, Chéret A, Goujard C, Rouzioux C, Caillat-Zucman S, Hocqueloux L, Scott-Algara D, Meyer L, Sáez-Cirión A; ANRS PRIMO cohort; VISCONTI study. Essat A, et al. Among authors: caillat zucman s. Med. 2025 Aug 8;6(8):100670. doi: 10.1016/j.medj.2025.100670. Epub 2025 Apr 28. Med. 2025. PMID: 40300610 Free article.
212 results